Clinical TrialID 178
Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease
NCT02220166
Celiac Disease
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 178
- Evidence Id
- 178
- Core Evidence Id
- 178
- Source Clinical Trial Id
- 171
- Herb2 Clinical Trial Id
- HBCT000171
- Nct Id
- NCT02220166
- Title
- Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Celiac Disease
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DIETARY_SUPPLEMENT: Triticum monococcum
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 8
- Outcome Measure
- Histologic: 4 duodenal biopsies obtained and classified according to Marsh, After 60 days of daily administration of Tm endoscopic biopsies were performed and reviewed by the same experienced pathologist, Baseline, Day 60
- Sponsor Collaborator
- Università degli Studi di Brescia
- Funded By
- OTHER
- Location
- AO Spedali Civili of Brescia, Brescia, I-25123, Italy
- Other Id
- GE-GA2-2010
- Start Date
- 2010-11
- Primary Completion Date
- 2011-07
- Completion Date
- 2011-08
- First Posted
- 2014-08-19
- Results First Posted
- Last Update Posted
- 2014-08-19
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT02220166
- Title Cn
- Title En
- Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease
- Bilingual Status
- semi_complete